Dow futures surge more than 700 points amid hope of coronavirus treatment
Published: April 16, 2020 at 7:51 p.m. ET
Gains were being partly attributed to a report from health-care media site Statthat indicated promising results from therapeutics used to treat the novel strain of coronavirus. The report indicated that 125 COVID-19 patients in a study were discharged after treatment with Gilead's remdesivir.
https://www.marketwatch.com/story/dow-futures-surge-nearly-700-points-in-after-hour-trade-thursday-evening-amid-hope-of-coronavirus-treatment-2020-04-16?mod=MW_article_top_stories
(Previously posted story below. No wonder the Chinese wanted to patent our work)
China lab seeks patent on use of Gilead's coronavirus treatment
BEIJING/SHANGHAI (Reuters) - A state-run Chinese research institute has applied for a patent on the use of Gilead Sciences’ experimental U.S. antiviral drug, which scientists think could provide treatment for the coronavirus that has killed hundreds and infected thousands.
The Wuhan Institute of Virology of the China Academy of Sciences, based in the city where the outbreak is believed to have originated, said in a statement on Tuesday it applied to patent the use of Remdesivir, an antiviral drug developed by Gilead (GILD.O), to treat the virus.
A study published in the New England Journal of Medicine last week reported a coronavirus patient in the United States was found to show an improvement after taking Remdesivir, which is also used to treat infectious diseases such as Ebola.
Scientists from both institutes said in a paper published in Nature’s Cell Research on Tuesday that they found both Remdesivir and Chloroquine, which is used to treat malaria, to be an effective way to inhibit the coronavirus.
The Wuhan-based laboratory said in its statement that the patent application was filed on Jan. 21 and aimed at protecting China’s national interests. However, it said it would temporarily drop its patent claims if the opportunity arose to collaborate with foreign pharmaceutical firms to fight the epidemic
https://www.reuters.com/article/us-china-health-patent/china-lab-seeks-patent-on-use-of-gileads-coronavirus-treatment-idUSKBN1ZZ0RL